Shannon John Patrick Jr
SEC insider (Form 3/4/5 filer). CIK 0001553595. Director at Xeris Biopharma Holdings, Inc. (XERS). 17 reported Form 4/5 transactions since Sep 2024; latest on Aug 1, 2026. Located in CHICAGO, IL.
Companies Shannon John Patrick Jr has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Director, Officer, See Remarks
Shannon John Patrick Jr
CIK: 0001553595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect36.6K shares at avg. $8.08$296K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect110.8K shares at avg. $7.36$815K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect111.6K shares at avg. $7.36$822K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect118.1K shares at avg. $7.36$869K - Jan 30, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect478.4K shares- - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect2.9K shares at avg. $3.94$11K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect64.3K shares at avg. $1.55$100K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect24.9K shares at avg. $7.08$176K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect25.1K shares at avg. $1.55$39K - Nov 14, 2025XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect87.1K shares at avg. $1.55$135K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 36,645 | $8.08 | $296,092 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 110,750 | $7.36 | $815,120 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 111,621 | $7.36 | $821,531 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 118,134 | $7.36 | $869,466 | Direct |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | Award | 478,436 | - | $0 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 2,900 | $3.94 | $11,426 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 64,265 | $1.55 | $99,611 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 24,907 | $7.08 | $176,257 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 25,136 | $1.55 | $38,961 | Direct |
| Nov 14, 2025 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 87,100 | $1.55 | $135,005 | Direct |
1-10 of 17 transactions